Jumpei Kondo

Associate Professor

Osaka University Graduate School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jumpei Kondo is an Associate Professor at Osaka University Graduate School of Medicine, Japan. His research primarily focuses on cancer biology, hepatology, and the regulatory mechanisms in tumor growth and differentiation. Recent articles authored by him explore various aspects such as the potential for targeted therapies in HBV infection, cellular polarity in malignancies, and the role of specific signaling pathways in colorectal cancer.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Keiji Ueda

Osaka University

JAPAN

View details

Kunishige Onuma

Program-Specific Assistant Professor

Kyoto University

JAPAN

View details

Masahiro Inoue

JAPAN

View details

Yoshihiro Kamada

Osaka University

JAPAN

View details

Takahiro Kodama

Assistant Professor

Osaka University

JAPAN

View details

Kensuke KANEKO

Assistant Professor

Nagaoka University of Technology

JAPAN

View details

Yoshiro Itatani

助教 / Assistant Professor

Kyoto University

JAPAN

View details

Eiji Miyoshi

Osaka University Graduate School of Medicine

JAPAN

View details

Junzo Hamanishi

准教授 / Associate Professor

Kyoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jumpei Kondo

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes

Dynamic change of polarity in spread through air spaces of pulmonary malignancies

Growth pattern of de novo small clusters of colorectal cancer is regulated by Notch signaling at detachment

Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer

Prohaptoglobin is a possible prognostic biomarker for colorectal cancer

Hepatocyte differentiation from mouse liver ductal organoids by transducing 4 liver-specific transcription factors

Transcription factor SP1 regulates haptoglobin fucosylation via induction of GDP-fucose transporter 1 in the hepatoma cell line HepG2

Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination

Enterococcus spp. have higher fitness for survival, in a pH‐dependent manner, in pancreatic juice among duodenal bacterial flora

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase–mediated hepatocyte transdifferentiation

Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix

Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma

Challenges in the application of glyco-technology to hepatitis b virus therapy and diagnosis

Correction to: Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix (Human Cell, (2021), 34, 3, (889-900), 10.1007/s13577-021-00511-5)

Collaborators (9)

Keiji Ueda

Kunishige Onuma

Masahiro Inoue

Yoshihiro Kamada

Takahiro Kodama

Kensuke KANEKO

Yoshiro Itatani

Eiji Miyoshi

Junzo Hamanishi

Make your next move.